News
Radioligand therapy (RLT) using Lu-177 labelled PSMA for metastatic prostate cancer
Radioligand therapy (RLT) using Lu-177 labelled PSMA is a novel and promising therapeutic approach to treat metastatic prostate cancer. We explain how the therapy works. Lu-177…
Read More
How Electricity Can Effectively Kill Cancer
Prostate cancer is the most common cancer in men, affecting 25% of all men. The standard treatments are time-consuming and associated with significant side effects.…
Read More
How Vitus Prostate Revolutionizes Virtual Real-time Precision Guidance for Prostate Cancer Treatment
The Vitus Prostate Center in Offenbach, Germany accompanies and advises the medical team of the Vitus Prostate Center San Diego in treatments of prostate cancer…
Read MoreVideo
Prof. Dr. Michael Stehling talks about the rationale and the advantages of using NanoKnife (IRE) for the treatment of prostate cancer.
NanoKnife (IRE) is the latest technology to treat prostate cancer. This short video demonstrates the out patient treatment of prostate cancer with NanoKnife (IRE).
Dr. Israel Barken independently reviewed our data and comments on the treatment of prostate cancer with NanoKnife (IRE).
